Evercore Wealth Management’s Immunogen Inc IMGN Stock Holding History

Evercore Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-10,000	Closed	-$106K	–	1013
2014 Q3	$106K	Hold	10,000	–	–	0.01%	506
2014 Q2	$119K	Hold	10,000	–	–	0.01%	483
2014 Q1	$149K	Hold	10,000	–	–	0.01%	414
2013 Q4	$147K	Hold	10,000	–	–	0.01%	401
2013 Q3	$170K	Sell	10,000 -20,000	-67%	-$352K	0.01%	411
2013 Q2	$498K	Buy	+30,000	New	+$486K	0.03%	280

Other funds holding IMGN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Evercore Wealth Management's IMGN Position: Q4 2014 in Review

Evercore Wealth Management sold out of Immunogen Inc (IMGN) in Q4 2014, closing a stake of 10,000 shares — an estimated $106K sold.

Evercore Wealth Management first reported a position in IMGN in Q2 2013 and held it in 6 quarters. The position peaked at $498K in Q2 2013. 131 funds tracked by Wall St. Rank hold IMGN as of Q4 2014.

Evercore Wealth Management reported no remaining Immunogen Inc position as of Q4 2014 after selling out during the quarter.
Evercore Wealth Management sold 10,000 Immunogen Inc shares in Q4 2014, an estimated $106K.
Evercore Wealth Management first reported a position in Immunogen Inc in Q2 2013 and held it in 6 quarters.
Evercore Wealth Management's Immunogen Inc position peaked at $498K in Q2 2013.
131 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2014.

Based on Evercore Wealth Management's 13F filing for Q4 2014, filed 13 Feb 2015.